Long-term Cardiovascular Outcomes After COVID-19-Associated Carditis

Overview

This retrospective cohort study evaluated long-term cardiovascular outcomes in patients who developed carditis during acute COVID-19 infection. The study found increased risks of major adverse cardiovascular events (MACE) and all-cause mortality up to five years post-infection compared to COVID-19 patients without carditis and historical carditis controls.

Background

Carditis, including myocarditis, pericarditis, and endocarditis, is an inflammatory cardiac condition often triggered by viral infections such as SARS-CoV-2. The virus can induce cardiac inflammation through direct myocardial infection via ACE2 receptors and an exaggerated immune response, leading to myocardial injury and remodeling. Early pandemic data showed a significant rise in acute myocarditis cases linked to COVID-19. However, the long-term cardiovascular consequences of COVID-19-associated carditis remain underexplored, especially by subtype.

Data Highlights

Key Findings

• Patients with COVID-19-associated carditis had significantly higher incidence of MACE and all-cause mortality compared to COVID-19 patients without carditis.
• The risk persisted up to five years post-acute infection, indicating long-term cardiovascular sequelae.
• Carditis subtypes (myocarditis, pericarditis, endocarditis) contributed variably to risk, with myocarditis showing the most pronounced adverse outcomes.
• Adjustments for demographics, comorbidities, socioeconomic factors, and unmet social needs did not eliminate the increased risk.
• Cardiac biomarkers (troponin T/I) and imaging (LVEF, CMR) during acute infection correlated with severity but long-term outcomes were independent predictors.

Clinical Implications

Clinicians should recognize that carditis during acute COVID-19 infection confers a sustained elevated risk for adverse cardiovascular events and mortality. Long-term cardiovascular monitoring and management strategies are warranted for these patients, including risk factor modification and surveillance for heart failure and arrhythmias. Awareness of socioeconomic and comorbidity factors is important but does not fully mitigate risk.

Conclusion

COVID-19-associated carditis is linked to significant long-term cardiovascular morbidity and mortality, underscoring the need for vigilant follow-up and targeted interventions in this high-risk population.

References

1. 1 -- Carditis as a complication of viral infections
2. 2 -- Cardiovascular involvement in SARS-CoV-2 infection
3. 3 -- Mechanisms of SARS-CoV-2 induced cardiac inflammation
4. 4 -- Endothelial dysfunction and myocardial injury in COVID-19
5. 5 -- Long-term myocardial remodeling post-COVID-19 carditis
6. 7,8,9 -- Epidemiology of myocarditis during COVID-19 pandemic
7. 10-18 -- Data extraction and validation methods